Introduction {#S1}
============

Melanized fungi of the order Chaetothyriales are renowned as agents of human infection. The number of cases is low when compared to dermatophytes, *Aspergillus*, and *Candida*, but with 86 species in 7 genera that have been proven as potential agents of vertebrate disease ([@B17]) the order ranges fourth in clinical biodiversity, after Onygenales, Eurotiales, and Saccharomycetales. In 19 chaetothyrialean species, systemic or disseminated infection has been observed, which frequently led to death of the patient. The neurotropic species *Cladophialophora bantiana* is one of the most feared fungi, because it causes brain abscesses in healthy-appearing patients, with a case fatality rate of 65% despite antifungal therapy ([@B38]). Numerous investigations nevertheless suggest that most members of the order -- with a possible exception of agents of chromoblastomycosis -- are opportunists rather than pathogens. Opportunists are defined as fungi that complete their natural life cycle without involvement of an animal host, being able of unintentional infection only through coincidental similarities between conditions of host tissue and natural habitat. [@B27] ascribed their infectious ability to polyextremotolerance, which is tolerance to environmental stress supplemented with efficient nutrient scavenging and toxin management. Properties that in pathogenic fungi have a role in virulence may have very different functionalities in the fungus' natural habitat. [@B58] noted that hypothesized virulence factors, which enhance infection in truly host-associated fungi like *Candida* or *Histoplasma*, in black yeasts may respond adversely to proxies of host resistance, and thus comparable genes can be functionally different between fungal groups.

An important consequence of opportunism is that all strains have an equal chance to be inoculated into the host, and thus clinical strains are not necessarily different from environmental ones. Pathogenic adaptation is then less likely to occur because of absence of host-related transmission. However, after coincidental inoculation, some strains may be more prone to cause symptoms than others, and thus there may be a difference between clinical and environmental strains. Black yeast-like fungi mostly cause local, (sub) cutaneous infections. The host conditions of patients with brain abscesses acquired via the inhalative route are not well understood. For disseminated cases, recent data have shown ([@B47]) that these are often associated with host-inherited mutations in caspase recruitment domain-containing protein 9 (CARD9). This protein plays a role in the dectin pathway regulating innate immunity activating pro-inflammatory cytokines. Since most cases of disseminated disease in black yeast-like fungi were described prior to 2013, it is possible that the majority of these cases occurred in patients with CARD9 dysfunctional innate immunity. Several of the infection types of chaetothyrialean fungi show a certain degree of unexplained endemism, such as the prevalence of *Cladophialophora* brain abscess in the Indian subcontinent ([@B11]). Similarly, the majority of CARD9-associated black fungal cases is found in East Asia: China, Korea, Japan, although the etiologic agents have a global distribution. For an explanation of virulence of members of Chaetothyriales, we thus might expect answers from the interaction of the fungus with windows of opportunity associated with CARD9 regulation and human race.

To study the fungal side of this tripartite relationship, we sequenced the genomes and transcriptomes with different culture conditions of an *Exophiala spinifera* strain isolated from a patient with a *CARD9*-related disorder, and compared this with two environmental strains of the same species, and with other published genomes ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). We applied state-of-the-art technology, to quantify eventual differences between clinical and environmental strains with maximum precision and to describe the species' intraspecific variability. A number of genomes of Chaetothyriales were already available, but these were sequenced with somewhat older techniques. One of the aims is therefore to describe the technical and biological variation in these datasets, and determine whether the new techniques provide a better answer to questions as formulated above.

Materials and Methods {#S2}
=====================

Literature Search {#S2.SS1}
-----------------

Keywords "CARD9" and "fungal infection" were used in PubMed to search the English literature including research articles, reviews and case reports published until November 2019.

Strains and Culture Conditions {#S2.SS2}
------------------------------

Three strains of *E. spinifera* were analyzed ([Table 1](#T1){ref-type="table"}): BMU 08022 (**ESC1**, from a CARD9-deficient patient, Jiangsu, China), BMU00051 (**ESE1**, from bark, Shenzen, China), and BMU00047 (**ESE2,** from soil, Colombia). To prepare DNA for genome sequencing, mycelia were harvested from fresh cultures on Sabouraud Dextrose Agar (SDA), frozen in liquid nitrogen, and stored at −80°C until further processing. For RNA extraction, strains were inoculated in Sabouraud Dextrose Broth (SDB) and in Brain Heart Infusion Broth (BHI) ([@B14]) and harvested after 20 h, centrifuged and frozen in liquid nitrogen. Liquid nitrogen was used to grind the samples for DNA/RNA extraction.

###### 

Isolation data of strains sequenced in this study, and isolates included for comparison.

  Strain ID     Species                   Country         Source                           GenBank Accession
  ------------- ------------------------- --------------- -------------------------------- -------------------
  BMU 08022     *E. spinifera*            China           Human skin (*CARD9* deficient)   JAAABF000000000
  BMU 00051     *E. spinifera*            China           Bark                             JAAABG000000000
  BMU 00047     *E. spinifera*            Colombia        Soil                             JAAABH000000000
  CBS 899.68T   *E. spinifera*            United States   Human nasal granuloma            JYBY00000000
  CBS 725.88T   *Exophiala oligosperma*   Germany         Human sphenoid abscess           JYCA01000000

DNA and RNA Extraction {#S2.SS3}
----------------------

Genomic DNA was extracted using the [MOBIO]{.smallcaps} Power Microbial Maxi DNA Isolation kit (MoBio Laboratories, Carlsbad, CA, United States). DNA was concentrated by [QUBIT]{.smallcaps} (Invitrogen, Carlsbad, CA, United States), and an Agilent Bio Analyzer 2100 using a 1000 DNA Chip (Agilent Technologies, Palo Alto, CA, United States), and its quality was determined by electrophoresis on agarose gels. Total RNA was extracted from cultures ground in liquid nitrogen using [TRIZOL]{.smallcaps} reagent (Thermo Fisher Scientific, Waltham, MA, United States) according to the manufacturer's instructions, followed by two phenol (pH 4.6)-chloroform-isoamyl alcohol (25:24:1) extraction steps and two chloroform extraction steps after the initial [TRIZOL]{.smallcaps}-chloroform phase separation. RNA pellets were dissolved in 88 μL of nuclease-free water and subjected to genomic DNA digestion with DNase (Qiagen, Hilden, Germany). RNA samples were then concentrated using RNA Clean & Concentrator (Zymo Research, Irvine, CA, United States). RNA quality was confirmed using an Agilent 2100 Bioanalyzer (Agilent). Two micrograms of total RNA per sample was used for cDNA library construction.

cDNA Synthesis {#S2.SS4}
--------------

The cDNA synthesis was performed using [IMPRON]{.smallcaps} II reverse transcriptase kit (Promega, Madison, WI, United States) with 1 μg of total RNA added according to manufacturer's instructions. The efficiency of the cDNA synthesis process was assessed by PCR using the following reference genes: β-tubulin and ITS. The integrity of PCR amplification products was verified by electrophoresis on 1.2% agarose gels.

PacBio Sequencing and Raw Assembly {#S2.SS5}
----------------------------------

The extracted DNA of three *E. spinifera* strains were sequenced on the Pacific Biosciences (Pacific Biosciences, Menlo Park, CA, United States) Single Molecule, Real-Time (SMRT) DNA sequencing technology (platform: RS II; chemistry: P6-C4). The raw reads were processed using the standard SMRT analysis pipeline v5.0.1 ([@B12]). The *de novo* assembly was carried out following [CANU]{.smallcaps} v1.4 assembly protocol ([@B41]) with [QUIVER]{.smallcaps} polishing ([@B12]). Assemblies were refined by manual curation. Pairwise alignments were carried out using [BLASTN]{.smallcaps} v2.6.0+ ([@B1]). The draft assemblies were further improved with [FINISHERSC (]{.smallcaps}[@B44][)]{.smallcaps} and polished with [ARROW]{.smallcaps} ([@B12]). For each genome assembly, contigs were examined and removed if redundant (i.e., aligning to any other contig in the same assembly with \>90% identity). All contigs containing rDNA repeats were excluded from the above step.

Illumina Sequencing, Read Mapping and Error Correction {#S2.SS6}
------------------------------------------------------

Our genome assembly strategy is summarized in [Figure 1](#F1){ref-type="fig"}. In addition to the [PACBIO]{.smallcaps} sequencing, we also performed Illumina 150-bp paired-end sequencing for each strain. We examined the raw Illumina reads via [FASTQC]{.smallcaps} v0.11.5^[1](#footnote1){ref-type="fn"}^ and performed adaptor-removal and quality-based trimming by [TRIMMOMATIC]{.smallcaps} v0.36 ([@B5]). For each strain, the trimmed reads were mapped to the corresponding [PACBIO]{.smallcaps} assemblies by [BWA]{.smallcaps} 0.7.12 and using [BWAMEM]{.smallcaps} v0.7.16 ([@B48]). The resulting read alignments were subsequently processed by [SAMTOOLS]{.smallcaps} v1.6 ([@B49]). On the basis of Illumina read alignments, we further performed error correction with [PILON]{.smallcaps} v1.22 ([@B60]) to generate final assemblies for downstream analysis. [BUSCO]{.smallcaps} v3 ([@B57]) was used to assess the completeness of the final assembled genomes.

![Genome assembly and annotation strategy used in this study. Assembly: the raw reads were processed using the standard SMRT analysis pipeline v5.0. The *de novo* assembly was carried out following [CANU]{.smallcaps} v1.4 assembly protocol with [QUIVER]{.smallcaps} polishing. Assemblies were refined by manual curation. Pairwise alignments were carried out using [BLASTN]{.smallcaps} v2.6.0+. The draft assemblies were further improved with [FINISHERSC]{.smallcaps} and polished with [ARROW]{.smallcaps}. Annotation: a hybrid strategy combining *ab initio* predictions and transcriptomic support (RNA-seq) was applied in gene prediction. Three *ab initio* gene finders, [GENEMARK.HMM]{.smallcaps}, [FGENESH]{.smallcaps}, and [AUGUSTUS]{.smallcaps} were used.](fmicb-11-01880-g001){#F1}

Repetitive Sequence Prediction and Masking {#S2.SS7}
------------------------------------------

Repetitive elements were predicted using a *de novo* approach by applying [REPEATMODELER]{.smallcaps} v1.0.11^[2](#footnote2){ref-type="fn"}^, which includes [RECON]{.smallcaps} v1.08 ([@B4]) and [REPEATSCOUT]{.smallcaps} v1.0.5 ([@B55]) to construct a strain-specific repeat library. To further classify repetitive sequences, [BLAST]{.smallcaps} v2.2.28 ([@B7]) was used to search the repeat library against [SWISS-PROT]{.smallcaps} protein database. Sequences with similarities to known proteins were discarded from the repeat library. Repetitive sequences were masked with [REPEATMASKER]{.smallcaps} v4.0.7^2^ using the *de novo* constructed library.

Annotation of rRNA, tRNA and Repeat Elements {#S2.SS8}
--------------------------------------------

The rRNA loci were predicted by using [RNAMMER]{.smallcaps} v1.2 ([@B43]) and tRNA by [TRNASCAN]{.smallcaps}-SE v2.0 ([@B52]). Repeat elements were identified using [REPEATMASKER]{.smallcaps} v4.0.6^2^ based on [REPBASE LIBRARY]{.smallcaps} 20160829. [REPEATMASKER]{.smallcaps} was run with options that skipped the low-complexity DNAs masking for the purpose of gene prediction.

Gene Prediction and Functional Annotation {#S2.SS9}
-----------------------------------------

A hybrid strategy combining *ab initio* predictions and transcript alignments was applied in annotation of protein coding genes. Firstly, protein coding genes were predicted using [BRAKER]{.smallcaps} ([@B34]), which was an *ab initio* approach combined with RNA-seq data. Then, RNA-seq was *de novo* assembled by using [TRINITY]{.smallcaps} ([@B29]). The assembled transcripts were aligned to the reference genome of corresponding strains by PASA pipeline ([@B31]). Finally, [EVIDENCEMODELER]{.smallcaps} ([@B32]) was used to combine *ab initio* predictions and transcript alignments into consensus gene structure.

Functional annotation of predicted proteins was done by [BLAST]{.smallcaps} ([@B7]) similarity search of the predicted proteins against NR database with an e-value of 1e--05. Gene Ontology (GO) terms were retrieved by using Blast2go ([@B28]) with default annotation parameters. To further improve the annotations, [INTERPROSCAN]{.smallcaps} v5.33-72.0 ([@B37]) was used to identify known protein domains. [BLAST]{.smallcaps} ([@B7]) results of NR database and results of the [INTERPROSCAN]{.smallcaps} analysis were combined to gain a complete functional annotation of all predicted genes. Genes predicted to encode carbohydrate-active enzymes ([CAZYMES]{.smallcaps}) were identified with [DBCAN2]{.smallcaps} ([@B64]). Also the software [SMURF]{.smallcaps} ([@B39]) was used to predict secondary metabolite gene clusters in three genomes of *E. spinifera*.

Comparison of Genome Assemblies {#S2.SS10}
-------------------------------

The synteny among three strains of *E. spinifera* was determined using [MUMMER]{.smallcaps} v3.23 ([@B18]). We used [NUCMER]{.smallcaps} implemented in [MUMMER]{.smallcaps} v3.23 to align the genomes of the three strains of *E. spinifera*. In addition, the [DNADIFF]{.smallcaps} package in [MUMMER]{.smallcaps} v3.23 was used to generate coordinates for the differences among genomes of the three strains analyzed. The alignment statistics, SNPs, indels, inversions, etc., were also calculated from the results of [MUMMER]{.smallcaps}. We plotted these features circularly with [CIRCOS]{.smallcaps} v0.69.6 ([@B42]).

Identification of Homology Groups {#S2.SS11}
---------------------------------

For nuclear protein-coding genes, we used [INPARANOID]{.smallcaps} v4.1^[3](#footnote3){ref-type="fn"}^ to identify gene homology across the three strains of *E. spinifera*. We calculated protein length distributions for each homologous group (1:1:1 association among strains) of the strains. The correlation of exon length and intron length of homologous groups (1:1 association between strains) were calculated by pairwise comparisons among three strains.

Identification of Orthologous Genes {#S2.SS12}
-----------------------------------

Orthologous groups were delimited using [ORTHOFINDER]{.smallcaps} v2.2.6 ([@B22]), in which all predicted protein sequences were compared using a [BLAST (]{.smallcaps}[@B7][)]{.smallcaps} all-against-all search. The single-copy genes, duplicated genes, and strain-specific genes were extracted from the [ORTHOFINDER]{.smallcaps} output. To detect the core genome, specific and shared genes, the data was filtered based on the [ORTHOFINDER]{.smallcaps} output. The R package [UPSETR (]{.smallcaps}[@B13][)]{.smallcaps} was used to construct statistics of orthologous groups among the three strains under study.

Identification of Genes Under Positive Selection {#S2.SS13}
------------------------------------------------

Single-copy orthologous proteins were aligned by using C[LUSTALO]{.smallcaps} v1.2.4^[4](#footnote4){ref-type="fn"}^. To obtain the alignments of codons, the corresponding nucleotide-sequence alignments were derived by substituting the respective coding sequences from the protein sequences. For each single-copy orthologous group, genes from the two environmental strains and their orthologous genes in the clinical strain formed sequence triplets. The test for the asymmetric evolution was constituted as a relative rate test between clinical strain and environmental strains on an unrooted tree. The statistical tests were conducted with a codon-based branch-site model using the C[ODEML]{.smallcaps} program of PAMLv4.9 ([@B63]). We compared ω0 and ω1 between single-copy orthologous genes to detect differences in proportion of selected sites in the two clades. Likelihood ratio (LR) was used to test for significance. To do this, two models were applied to the data: model 1 (ω0 = ω1) constrains the two ω values to be equal for the three sequences, and model 2 (ω0 ≠ ω1) estimates the two ω values as free parameters. Collected maximum likelihood values ML1 and ML2 from the two models were used to calculate the LR, LR = 2 (lnML2−lnML1). LR is then compared against the χ^2^ distribution with one degree of freedom.

Transcriptome Analysis {#S2.SS14}
----------------------

The raw reads were assessed for quality by [FASTQC]{.smallcaps} v0.11.5 and filtered to remove low-quality reads with [TRIMMOMATIC]{.smallcaps} v0.36 ([@B5]). Filtered reads were mapped to the corresponding reference genome of three *E. spinifera* strains using [STAR]{.smallcaps} v2.5.3a ([@B19]). The gene expression levels were calculated using [FEATURECOUNTS]{.smallcaps} v1.5.2 ([@B50]) and normalized based on the [FPKM]{.smallcaps} method. Differentially expressed genes were detected by R package [DESEQ2]{.smallcaps} ([@B51][)]{.smallcaps}. Differentially expressed genes were filtered by adjusted *p*-value \< 0.05 and \| log2 fold change\| \> 1. GO enrichment analysis was performed by R package [TOPGO]{.smallcaps}^[5](#footnote5){ref-type="fn"}^. Only 1-1-1 orthologous genes were considered when detecting differentially expressed genes among different strains. For analysis of RNA-seq data, differentially expressed genes were detected by R Bioconductor package DESeq2 with the Benjamini-Hochberg adjusted *p*-value \< 0.05 and fold change \>2. Student's *t*-tests were performed for the comparisons, and a *p-*value \< 0.05 was considered to represent significance.

Data Availability {#S2.SS15}
-----------------

All genomes and RNA-seq have been deposited in NCBI. The RNA-seq data can be accessed by PRJNA600825, the [PACBIO]{.smallcaps} assemblies (PRJNA600825), Illumina assemblies (PRJNA600036). The RNA-seq is available already (<https://www.ncbi.nlm.nih.gov/sra/PRJNA600825>).

Results {#S3}
=======

Literature Data on Black Fungi in CARD9 Patients {#S3.SS1}
------------------------------------------------

An overview was made of published cases of fungal infections in patients with CARD9 deficiencies ([Table 2](#T2){ref-type="table"}; [@B26]; [@B20]; [@B47], [@B45],[@B46]; [@B24], [@B25]; [@B21]; [@B30]; [@B33]; [@B36]; [@B2]; [@B9]; [@B62]; [@B6]; [@B65]; [@B3]; [@B10]; [@B15]; [@B67]; [@B35]). Sixteen different mutations have been observed. When cases are arranged according to phylogeny of the fungus, three main groups can be recognized: ascomycetous yeasts (*Candida*: order Saccharomycetales), dermatophytes (order Onygenales), and black fungi (mainly order Chaetothyriales, single representatives of orders Pleosporales and Venturiales). A single proven case with a member of Mucorales has been published. Mutations are not randomly distributed in the three fungal groups ([Figure 2](#F2){ref-type="fig"}; *p* = 0.001). For example, p.Q295X is found in 13 cases of *Candida* infection, but was not found among cases by other fungi. The main cytokine impaired was IL-6 (43/50 cases). In Onygenales, this was the only deficient cytokine reported, while, in contrast, in seven cases of *Candida* infection GM-CSF or TNFα were absent instead. Black fungi were associated with a relatively large panel of missing cytokines, particularly TNFα and IL-1β. The relative absence of cytokines in the three fungal main groups is illustrated in [Figure 3](#F3){ref-type="fig"}.

###### 

Overview of published cases of fungal infection in patients with *CARD9* deficiency.

  Origin                   Outcome   Clinical                               Species                                                          Mutation type                   Cytokine deficiency                            References
  ------------------------ --------- -------------------------------------- ---------------------------------------------------------------- ------------------------------- ---------------------------------------------- ------------
  **Saccharomycetales:**                                                                                                                                                                                                    
  Iran                     Died      CNS                                    *Candida albicans*                                               NR                              NR                                             [@B26]
  Iran                     Died      CNS, skin                              *C. albicans*                                                    NR                              NR                                             [@B26]
  Iran                     Died      CNS, mucosa                            *C. albicans*                                                    NR                              NR                                             [@B26]
  Iran                     Chronic   Mucosa                                 *C. albicans*                                                    p.Q295X                         TNFα, IL-17A                                   [@B26]
  Iran                     Chronic   Skin                                   *C. albicans*                                                    p.Q295X                         TNFα, IL-17A                                   [@B26]
  Iran                     Chronic   Oral, vagina, skin                     *C. albicans*                                                    p.Q295X                         TNFα, IL-17A                                   [@B26]
  Iran                     Chronic   Vagina, skin                           *C. albicans*, dermatophyte                                      p.Q295X                         TNFα, IL-17A                                   [@B26]
  Asia                     Chronic   CNS                                    *Candida dubliniensis*                                           p.R373P/p.G72S                  IL-6, IL-1β, IL-8, IL-17A                      [@B20]
  France                   Chronic   CNS                                    *C. albicans*                                                    p.Y91H                          GM-CSF                                         [@B24]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    p.Q295X                         IL-6, TNFα, IL-1β                              [@B33]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    p.Q295X                         NR                                             [@B9]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    p.R70W                          IL-6, TNFα                                     [@B45]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    p.R70W                          IL-6, TNFα                                     [@B46]
  Iran                     Chronic   CNS, sinus, digestive system           *Candida glabrata*                                               p.R35Q                          IL-6, TNFα                                     [@B45]
  Morocco                  Chronic   CNS                                    *C. albicans*                                                    p.Q289X                         NR                                             [@B46]
  Pakistan                 Chronic   Digestive system                       *C. albicans*                                                    p.Q295X                         IL-6, TNFα                                     [@B46]
  Canada                   Chronic   CNS                                    *C. albicans*                                                    p.Y91H                          GM-CSF                                         [@B25]
  Canada                   Chronic   CNS, spine                             *C. albicans*                                                    p.Y91H                          GM-CSF                                         [@B25]
  United States            Chronic   CNS, bone                              *C. albicans*                                                    p.R57H                          GM-CSF                                         [@B21]
  Turkey                   Chronic   Mucosa                                 *C. albicans*                                                    p.R70W                          IL-6, TNFα, IFNγ, IL-1β, IL12p70               [@B2]
  Turkey                   Chronic   CNS, mucosa                            *C. albicans*                                                    NR                              IL-6, GM-CSF, IL-22, IL-17A                    [@B2]
  Asia                     Chronic   CNS                                    *C. dubliniensis*                                                G72S/R373P                      NR                                             [@B15]
  El Salvador              Chronic   CNS, osteomyelitis                     *C. albicans*                                                    R57H/R57H                       IL-6, IL-17A                                   [@B15]
  Canada                   Chronic   CNS                                    *C. albicans*                                                    Y91H/Y91H                       IL-6, IL-17A                                   [@B15]
  Canada                   Chronic   CNS                                    *C. albicans*                                                    Y91H/c.-529T\>C                 IL-6, IL-17A                                   [@B15]
  Canada                   Chronic   CNS, vertebral osteomyelitis           *C. albicans*                                                    Y91H/c.-529T\>C                 IL-6, IL-17A                                   [@B15]
  **Saccharomycetales:**                                                                                                                                                                                                    
  Canada                   Chronic   CNS                                    NA                                                               Y91H/c.-529T\>C                 IL-6, IL-17A                                   [@B15]
  Iran                     Chronic   CNS                                    *Candida* sp.                                                    Q295X/Q295X                     IL-6, IL-17A                                   [@B15]
  Iran                     Chronic   CNS                                    *Candida* sp.                                                    NA                              NA                                             [@B15]
  Iran                     Chronic   CNS                                    *Candida* sp.                                                    NA                              NA                                             [@B15]
  Morocco                  Chronic   CNS, papillary edema                   *C. albicans*                                                    Q289X/Q289X                     IL-6, IL-17A                                   [@B15]
  Iran                     Chronic   CNS                                    *C. glabrata*                                                    R35Q/R35Q                       IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    R70W/R70W                       IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    R70W/R70W                       IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    NA                              NA                                             [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    Q295X/Q295X                     IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    Q295X/Q295X                     IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans*                                                    Q295X/Q295X                     IL-6, IL-17A                                   [@B15]
  Turkey                   Chronic   CNS                                    *C. albicans* (*Aspergillus* unconfirmed)                        Q295X/Q295X                     lL-6                                           [@B15]
  Europe                   Chronic   CNS                                    *C. albicans, Aspergillus fumigatus*                             Q295X/Q295X                     IL-6                                           [@B15]
  **Onygenales:**                                                                                                                                                                                                           
  Algeria                  Chronic   Nail                                   *Trichophyton* sp.                                               p.Q289X                         IL-6, IL-17A                                   [@B47]
  Morocco                  Chronic   Skin, nail, bone, lymph nodes          *Trichophyton rubrum*                                            p.R101C                         NR                                             [@B47]
  Morocco                  Chronic   Head, nail                             *Trichophyton* sp.                                               p.R101C                         IL-6, IL-17A                                   [@B47]
  Tunisia                  Died      Skin, head, nail                       *Trichophyton* sp.                                               p.Q289X                         IL-6, IL-17A                                   [@B47]
  Tunisia                  Chronic   Head, nail                             *T. rubrum*                                                      p.Q289X                         NR                                             [@B47]
  Tunisia                  Chronic   Skin, head, nail, lymph nodes          *T. rubrum, Trichophyton Violaceum*                              p.Q289X                         IL-6, IL-17A                                   [@B47]
  Tunisia                  Chronic   Skin, head, nail, lymph nodes          *T. rubrum, T. violaceum*                                        p.Q289X                         IL-6, IL-17A                                   [@B47]
  Egypt                    Chronic   Skin, nail                             *T. rubrum*                                                      p.Q289X                         IL-6, IL-17A                                   [@B36]
  Brazil                   Chronic   Skin                                   *Trichophyton mentagrophytes*                                    p.R101L                         NR                                             [@B30]
  Algeria                  Chronic   Skin, nail, head, lymph nodes, CNS     *T. rubrum*                                                      p.Q289X                         IL-6, IL-17A                                   [@B6]
  Turkey                   Chronic   Skin, nail, oral cavity, lymph nodes   *T. rubrum, T. violaceum, Trichophyton verrucosum, Malassezia*   p.R70W                          IL-6, IL-17A                                   [@B2]
  Algeria                  Died      CNS                                    *T. violaceum*                                                   NA (family member with Q289X)   IL-6, IL-17A                                   [@B15]
  **Chaetothyriales:**                                                                                                                                                                                                      
  China                    Chronic   Skin                                   *Phialophora verrucosa*                                          p.L64fsX59/p.Q158X              IL-6, TNFα, IL-1β, IL-23p19                    [@B60]
  China                    Chronic   Skin                                   *P. verrucosa*                                                   p.D274fsX60                     IL-6, TNFα, IL-1β, IL-23p19                    [@B60]
  China                    Chronic   Skin                                   *P. verrucosa*                                                   p.D274fsX60                     IL-6, TNFα, IL-1β, IL-23p19                    [@B61]
  China                    Chronic   Skin                                   *P. verrucosa*                                                   p.D274fsX60                     IL-6, TNFα, IL-1β, IL-23p19                    [@B64]
  China                    Chronic   Skin, mucosa, sinus, CNS               *P. verrucosa*                                                   p.R35Q/p.E81K                   IL-6, TNFα                                     [@B64]
  Angola                   Chronic   Liver, CNS                             *Exophiala dermatitidis*                                         p.R18W                          NR                                             [@B45]
  Iran                     Chronic   Skin, bone, lung                       *E. spinifera*                                                   p.E232del                       IL-6, TNFα, IL-1β, IFNγ, IL17, IL-22, GM-CSF   [@B46]
  China                    Chronic   Skin                                   *E. spinifera*                                                   p.S23X/p.D274fsX60              IL-6, TNFα, IL-1β, IL-17A, IL-22, GM-CSF       [@B15]
  Angola                   Chronic   CNS                                    *E. dermatitidis*                                                R18W/R18W                                                                      [@B15]
  China                    Chronic   Skin                                   *Periplaneta americana*                                          p.D274fsX60                     IL-6, TNFα, IL-1β                              [@B35]
  **Venturiales:**                                                                                                                                                                                                          
  China                    NR        Skin                                   *Ochroconis musae*                                               p.D274fsX60                     IL-6, TNFα, IL-1β, IL-17A, IL-22, GM-CSF       
  **Pleosporales:**                                                                                                                                                                                                         
  China                    NR        Skin, mucosa                           *Corynespora cassiicola*                                         p.L64fsX59/p.D274fsX60          IL-6, TNFα, IL-1β, IL-17A, IL-22, GM-CSF       [@B62]
  China                              Skin                                   *Corynespora cassiicola*                                         c.191--192InsTGCT, p.L64fsX59                                                  [@B62]
  Colombia                           face                                   *Corynespora cassiicola*                                         c.23_29del; p.Asp8Alafs10                                                      
                                                                                                                                             c.865C \>T, p.Q289                                                             [@B3]
  **Mucorales:**                                                                                                                                                                                                            
  China                    Chronic   Skin                                   *Mucor irregularis*                                              c.692C\>T/c.905_907delTCT       NR                                             [@B62]

![Overview of *CARD9* mutations in published cases of fungal infections in patients with CARD9 deficiencies. Sixteen different mutations have been observed. Three main groups can be recognized: ascomycetous yeasts (*Candida*: order Saccharomycetales), dermatophytes (order Onygenales), and black fungi (mainly order Chaetothyriales, single representatives of orders Pleosporales and Venturiales). A single proven case with a member of Mucorales has been published. Mutations are not randomly distributed in the three fungal groups.](fmicb-11-01880-g002){#F2}

![The relative absence of cytokines in the three fungal main groups is illustrated. The main cytokine impaired in *Candida* infection was IL-6. GM-CSF or TNFα were absent in seven cases of *Candida* infection. In Onygenales, IL-6 was the only deficient cytokine reported. Black fungi were associated with a relatively large panel of missing cytokines, particularly TNFα and IL-1β.](fmicb-11-01880-g003){#F3}

Genome Sequencing and Assembly {#S3.SS2}
------------------------------

We sequenced the genomes of three strains: BMU 08022 (clinical strain from human skin, **ESC1**), BMU 00051 (environmental strain from bark, **ESE1**), and BMU 00047 (environmental strain from soil, **ESE2**) ([Table 1](#T1){ref-type="table"}) using a combination of long-read ([PACBIO]{.smallcaps}) and short-read (Illumina) sequencing technologies. The third generation sequencing is supplemented by the second generation sequencing, and combined with a variety of assembly software and parameter optimizations ([Figure 1](#F1){ref-type="fig"}). For each genome, [PACBIO]{.smallcaps} sequencing provided more than 100 × coverage and Illumina reached 170× coverage. For strain ESC1, we obtained a draft genome assembly of 33,559,924 bp organized into nine contigs with an L90 of 7, and an N50 of 4.0 Mb. The genome of ESE1 was 32,380,025 bp in size and comprised seven contigs with an L90 of 7, and N50 of 4.9 Mb. In ESE2, the genome assembly of 32,696,644 bp contained nine contigs with an L90 of 7, and an N50 4.6 Mb. For all three strains, more than 94% of the Illumina reads were aligned to the draft genome assemblies in *post hoc* validation ([Table 3](#T3){ref-type="table"}). The results of genome assembly of the three strains reached sub-chromosome level.

###### 

Genome assembly of analyzed strains of *Exophiala spinifera*, compared with deposited genomes of *E. spinifera* (CBS 899.68) and *E. oligosperma* (CBS 725.88).

                          ESC1            ESE1            ESE2            CBS 899.68   CBS 725.88
  ----------------------- --------------- --------------- --------------- ------------ ------------
  Genome size (bp)        33,559,924      32,380,025      32,696,644      32,912,300   38,224,500
  Number of contigs       9               7               9                            
  Number of scaffolds     8               7               7               28           143
  L90                     7               7               7                            
  N50 (bp)                4,048,587       4,872,376       4,635,272                    
  GC content              51.8%           51.9%           51.7%           51.7%        50.4%
  CEGMA                   236 (95.2%)     236 (95.2%)     237 (95.6%)                  
  BUSCOs                  1,282 (97.5%)   1,276 (97.1%)   1,274 (96.9%)                
  Number of genes         12,130          12,072          12,043          12,110       11,938
  Number of proteins      12,131          12,074          12,043          12,049       13,234
  Mean gene length (bp)   2,006           2,012           1,979                        
  Mean number of exons    2.84            2.92            2.87                         
  Genome coding           72.4%           75.0%           72.9%                        
  Coverage of InterPro    78.8%           77.6%           77.9%                        
  Coverage of GO          70.8%           70.0%           70.5%                        
  rRNA                    18              28              21              16           4
  tRNA                    42              44              44              45           41
  Genome coverage         103×            122×            110×            272×         240×
  Sequencing technology   PacBio          PacBio          PacBio          Illumina     Illumina

CEGMA, Core Eukaryotic Genes Mapping Approach; BUSCOs, Benchmarking Universal Single-Copy Orthologs.

Colinear Analysis {#S3.SS3}
-----------------

We used whole-genome alignment to identify homologous and strain-specific segments among three *E. spinifera* strains. We identified a total of 172,269 and 170,807 SNPs for the clinical strain compared to the environmental strains BMU 00051 and BMU 00047, respectively ([Table 4](#T4){ref-type="table"}). However, the number of SNPs between the environmental strains was 362,264, which indicated that the genome of the clinical strain was intermediate between the two environmental strains from different continents. Likewise, the number of indels identified in the clinical strain was higher than compared with environmental strains ([Table 4](#T4){ref-type="table"}). There were 105,095 (ESE1) / 104,446 (ESE2) synonymous vs. 67,174 (ESE1) / 66,361 (ESE2) non-synonymous SNPs compared to clinical strain ESC1 ([Table 4](#T4){ref-type="table"}). We found substantial syntenic rearrangements in scaffolds I and III between ESC1 vs. ESE1 and ESC1 vs. ESE2, while in scaffolds VII and VIII of ESC1 syntenic rearrangements existed with scaffold III of ESE1 ([Figure 4](#F4){ref-type="fig"}). Comparing the genomes of ESC1, ESE1, and ESE2, recombination was observed in scaffolds I and III between the clinical and environmental strains ([Figure 4B](#F4){ref-type="fig"}). Scaffold I of ESC1 is equal to part of scaffolds I and III of the environmental strains, and scaffold III of ESC1 is equal to the remainders of scaffolds I and III of the environmental strains. This is shown in more detail in [Figure 4](#F4){ref-type="fig"}, where scaffold VIII of ESC1 is shown to be comparable to part of scaffold I of the environmental strains, and two areas proved to be inverted between clinical and environmental strains.

###### 

Comparison of single nucleotide polymorphisms of clinical vs. environmental strains.

                             ESC1 vs. ESE1   ESC1 vs. ESE2
  -------------------------- --------------- ---------------
  Synonymous SNP             105,095         104,446
  Non-synonymous SNP         67,174          66,361
  Frameshift deletion        1,231           1,152
  Frameshift insertion       1,124           1,133
  Non-frameshift insertion   965             962
  Non-frameshift deletion    939             909
  Stopgain                   701             849
  Stoploss                   153             150

![Genome colinear analysis for the three *E. spinifera* genomes. **(A)** Recombination is observed between clinical strain ESC1 and environmental strains ESE1 and ESE2 in scaffolds I and III. Track 1, genome position; track 2, gene density; track 3, sequence synteny. Orange diamonds: telomere sequences. **(B)** Location of sequence rearrangements in scaffolds I and III of ESC1. Red, stands for positive collinearity; Blue, reverse complementary.](fmicb-11-01880-g004){#F4}

Gene Content and Functional Annotation {#S3.SS4}
--------------------------------------

Genome functional annotation was performed with [INTERPROSCAN]{.smallcaps}, resulting in over 59% of genes being protein-coding genes annotated with GO term. A hybrid strategy combining *ab initio* predictions and transcriptomic support (RNA-seq) was applied in gene prediction. Annotation of the strains yielded 12,131 protein-coding genes for *E. spinifera* ESC1, 12,074 protein-coding genes for ESE1 and 12,043 for ESE2 ([Table 3](#T3){ref-type="table"}). A total of 9,887 genes represented the core genome ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}). The environmental strains shared more genes (336) than compared with clinical strain ESC1. The clinical strain had 647 specific gene clusters, included transporter, and binding protein. The list of the respective functional annotations is available in [Supplementary Table S2](#TS2){ref-type="supplementary-material"}. Plotting the protein lengths of the three strains, considerable differences were noted ([Figure 5](#F5){ref-type="fig"}): the distribution pattern of strain-specific genes length varied from clinical strain ESC1 to environmental strain, and ESC1 deviated by having more genes. Single-copy orthologous genes were compared to detect differences in proportion of selected sites, with LR as test of significance. In contrast, homologous introns were weakly correlated between ESC1 and environmental strain (ESE1 and ESE2), with significant length variations, while correlation were present between environmental strains (*r*^2^ = 0.57, higher than the other two groups) ([Figure 6](#F6){ref-type="fig"}).

![Distribution variability of specific protein length among three strains. The protein lengths (*Y*-axis) in strains analyzed (*n* = *X*-axis) showing an intraspecific variability. Greater differences were found between clinical strain ESC1 and environmental strains ESE1 and ESE2, while the protein length distribution of the two environmental strains was more consistent.](fmicb-11-01880-g005){#F5}

![Length variations of introns and exons. The blue lines show trends in exon length distribution, the slopes being different between exons and intron. Positive and negative correlations are shown. Homologous introns were weakly correlated, with significant length variations.](fmicb-11-01880-g006){#F6}

Secondary Metabolite Clusters {#S3.SS5}
-----------------------------

We identified a total of 9,329 homologous groups at the gene level (1:1:1 association among three strains). In the assumption that the core genomes with basic metabolic functions have similar biological functions, we focused on secondary metabolites. Seventeen gene clusters were involved in the production of secondary metabolites ([Figure 7](#F7){ref-type="fig"}). Clusters 1, 2, 4, 14, and 16 are PKS-related clusters. Cluster 16 is present in environmental strain ESE2 only. The cluster contains the single-copy gene benzoate 4-monooxygenase cytochrome P450, which catalyzes the benzoate degradation step in the toluene catabolic pathway ([Table 5](#T5){ref-type="table"}).

![Genome comparison of secondary metabolite clusters of three strains. Seventeen gene clusters were involved in the production of secondary metabolites. Environmental strains ESE1 and ESE2 are predicted to have more secondary metabolite clusters than the clinical strain ESC1.Clusters 1, 2, 4, 14, and 16 are PKS-related clusters. Cluster 16 is present in environmental strain ESE2 only.](fmicb-11-01880-g007){#F7}

###### 

Function of specific secondary metabolic gene clusters.

  Cluster ID   Strain          Backbone
  ------------ --------------- ------------------------------------------------
  Cluster 3    ESE1 and ESE2   L-aminoadipate-semialdehyde dehydrogenase
  Cluster 10   ESE2            Putative acyl-coenzyme A synthetase
  Cluster 11   ESE1            Nonribosomal peptide synthase Pes1
  Cluster 12   ESE1 and ESE2   Beta-ketoacyl-acyl-carrier-protein synthase II
  Cluster 15   ESE1            Nonribosomal peptide synthase GliP
  Cluster 16   ESE2            Polyketide synthase, putative
  Cluster 17   ESE2            NRPS-like enzyme

RNA-seq {#S3.SS6}
-------

Sequence clustering at the mRNA level was used to compare the three strains to identify homologous groups among the three strains. For all three strains, poly (A)-enriched, strand-specific RNA-seq from two cultivation conditions (SDB and BHI broth) with different culture degrees was performed. Comparison of differentially expressed genes under different culture conditions demonstrated that ESC1 revealed significant differences in response to the two media in 16 single-copy genes, while the environmental strains ESE1 and ESE2 remained almost indifferent ([Figure 8](#F8){ref-type="fig"} and [Supplementary Table S3](#TS4){ref-type="supplementary-material"}).

![Comparison of differentially expressed genes upon incubation in SDB and BHI broth. Clustering of deviations from zero and shown in a dendrogram by complete linkage hierarchical clustering using Euclidean distance. All tests are shown in duplicate. The results demonstrated that ESC1 revealed significant differences in response to the two media in 16 genes, while the environmental strains ESE1 and ESE2 remained almost indifferent.](fmicb-11-01880-g008){#F8}

There were 48 unique genes (22 in BHI media and 26 genes in SDB media; [Table 6](#T6){ref-type="table"}) involved in metabolism and transcriptional regulation differentially expressed exclusively in the clinical strain compared to the two environmental strains, including 12 genes without functional annotation. [Supplementary Table S4](#TS5){ref-type="supplementary-material"} displays the functional gene content (name, IPR families, KOG, and GO) and respective expression levels in each scenery/media, to enable the visualization/filters of this data. The table includes the gene ID, description, IPR numbers and the GO information. Differentially expressed genes between clinical isolate and environmental isolates under BHI culture are listed in [Supplementary Table S5](#TS5){ref-type="supplementary-material"}. There were 637 up-regulated genes between ESC1 and ESE1, and 659 up-regulated genes between ESC1 and ESE2. These specific upregulated genes in the clinical strain mainly act in transmembrane transport, translational elongation, ribosome biogenesis, and some other biosynthetic processes (GO enrichment results are summarized in [Supplementary Table S6](#TS5){ref-type="supplementary-material"}). GO analysis showed that the gene annotations were mainly in three categories: biological processes (BP), molecular function (MF), and cell component (CC). GO categories among three strains showed a similar enrichment distribution ([Supplementary Figure S2](#FS2){ref-type="supplementary-material"}). However, GO annotations of genes unique to each strain were not identical in BP and MF ontologies. In the biological process, the differentially expressed genes were mainly enriched in response to cellular process and metabolic process. In the MF, differentially expressed genes were mainly related to binding and catalytic activity ([Supplementary Figure S3](#FS3){ref-type="supplementary-material"}).

###### 

Unique genes differentially expressed exclusively in the clinical strain.

  Gene Ontology                                                                        Total genes   Media
  ------------------------------------------------------------------------------------ ------------- -------
  NA (NA)                                                                              10            SDB
  integral component of membrane (GO:0016021)                                          6             SDB
  NA (NA)                                                                              2             BHI
  nucleus (GO:0005634)                                                                 2             BHI
  oxidation-reduction process (GO:0055114)                                             2             BHI
  oxidoreductase activity (GO:0016491)                                                 2             BHI
  zinc ion binding (GO:0008270)                                                        2             BHI
  carbon-sulfur lyase activity (GO:0016846)                                            2             SDB
  DNA-binding transcription factor activity (GO:0003700)                               2             SDB
  GTP binding (GO:0005525)                                                             2             SDB
  ligase activity (GO:0016874)                                                         2             SDB
  methylation (GO:0032259)                                                             2             SDB
  methyltransferase activity (GO:0008168)                                              2             SDB
  phosphopantetheine binding (GO:0031177)                                              2             SDB
  regulation of transcription, DNA-templated (GO:0006355)                              2             SDB
  transcription factor complex (GO:0005667)                                            2             SDB
  transmembrane transport (GO:0055085)                                                 2             SDB
  catalytic activity (GO:0003824)                                                      1             BHI
  integral component of membrane (GO:0016021)                                          1             BHI
  protein transport (GO:0015031)                                                       1             BHI
  ATP binding (GO:0005524)                                                             1             SDB
  cytoplasm (GO:0005737)                                                               1             SDB
  DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981)   1             SDB
  nucleus (GO:0005634)                                                                 1             SDB
  regulation of transcription by RNA polymerase II (GO:0006357)                        1             SDB
  ribosome (GO:0005840)                                                                1             SDB
  RNA binding (GO:0003723)                                                             1             SDB
  transferase activity (GO:0016740)                                                    1             SDB
  zinc ion binding (GO:0008270)                                                        1             SDB

The correlation between differential expression genes and positive selection genes are listed in [Supplementary Table S7](#TS6){ref-type="supplementary-material"}. There were 53 positively selected genes that were also up-regulated between ESC1 and ESE1 in BHI culture. Comparing ESC1 and ESE2 under BHI conditions, 53 positively selected genes were also up-regulated in ESC1. A total of 29 positively selected genes were up-regulated in ESC1 when compared with both ESE1 and ESE2 in BHI broth. These genes were involved in positive regulation of translation, regulation of translational termination, and ATP synthesis coupled proton transport.

Genes Under Positive Selection {#S3.SS7}
------------------------------

Models 1 (ω0 = ω1) and 2 (ω0 ≠ ω1) were used to estimate the ω values as free parameters, with LRs as parameters of significance. A total of 29 genes yielded significant values indicating positive selection (*p* ≤ 0.0001) ([Supplementary Table S8](#TS1){ref-type="supplementary-material"}). These genes were subjected to GO analysis and were mainly enriched for BP, including cellular response, positive regulation of phosphorylation and transferase activity. Some replication- and transcription-associated genes and several structural protein genes were also discovered under positive selection ([Supplementary Table S9](#TS1){ref-type="supplementary-material"}).

Discussion {#S4}
==========

Black yeasts are generally considered to be opportunists; consequently, they should lack any specialized adaptation to the vertebrate host ([@B56]). Infection is coincidentally promoted by factors that enhance survival in the environmental niche of the fungus. Such factors must be present in chaetothyrialean black fungi, given the relatively large number of species reported from infections in humans and in cold-blooded animals. The Chaetothyriales are particularly over-represented in patients with inherited deficiencies in caspase recruitment domain-containing signaling protein 9 (CARD9), a disorder impairing the dectin pathway of innate immunity. This protein enhances pattern recognition receptors to induce NF-κB and MAPK activation, leading to a cytokine cascade. Malfunctioning of the protein decreases protection against infection by larger microbes such as parasites and especially fungi. It has been puzzling why the patients, theoretically being susceptible to any fungal infection, usually carry only a single species. Reviewing the 77 fungal cases published to date ([Table 1](#T1){ref-type="table"}), a possible explanation might be found in the fact that this protection deficiency appears to be highly specific. Only three groups of fungi are prevalent: *Candida* spp. (order Saccharomycetales), dermatophytes (order Onygenales) and black fungi of the order Chaetothyriales. A single case of *Mucor irregularis* has been published. This is the only species of *Mucor* that is known to cause chronic infections in apparently healthy individuals ([@B53]), other Mucorales being acute in compromised patients. As noted by [@B59], there is a regional bias in CARD9 deficiency cases in that the great majority of cases by *Candida* and dermatophytes are from northern Africa, Turkey, and Iran, while chaetothyrialean cases are particularly encountered in East Asia. Notably, severe and chronic black fungal infections are well-known in China ([@B17]). However, most cases of disseminated fungal infection in "healthy" patients were published before CARD9 deficiency was discovered, thus the possibility is not excluded that more patients had a hidden inherited immune disorder. Remarkably, common opportunists such as *Aspergillus* or *Fusarium* are nearly or completely lacking. The over-representation of chaetothyrialean black fungi in this susceptible patient population is also striking because such infections are rare in other patient cohorts, in healthy as well as in otherwise immunocompromised hosts. In black fungi, i.e., members of Chaetothyriales, Pleosporales, and Venturiales, 40% of the mutations were heterozygous. Mutation types tend to be different between the groups of yeasts, dermatophytes, and black fungi ([Figure 2](#F2){ref-type="fig"}): black fungi responded to other mutations than yeasts and dermatophytes. Also the affected cytokines differed between groups.

From these data it is obvious that black fungi, and particularly those belonging to the order Chaetothyriales, respond in a rather specific manner to impairment of the human immune system. Comparing the three main groups (yeasts, dermatophytes, black fungi) with respect to their response to cytokines, quite remarkably, the patients with chronic dermatophyte infections all were reported to have IL-6 deficiency alone, while in black fungi TNFα and often also IL-17A were impaired ([Figure 3](#F3){ref-type="fig"}). In *Candida*, a more variable picture was observed, but IL-6 deficiency was observed in 23 out of 31 cases. IL-6 is a proinflammatory cytokine controlling T-cell differentiation, particularly Th17 and regulatory T cells ([@B66]). These conclusions should however be taken with some care, as cytokine measurements were not consistent between publications.

The data are nevertheless sufficient to surmise that black fungal infections, particularly of members of Chaetothyriales, are not randomly occurring in susceptible patients with impaired immunity in general, but respond specifically to the conditions provided by CARD9 impairment. Because of their pronounced ability to decompose monoaromatic toxins, black yeasts of this order are enriched in the domestic environment ([@B54]), and therefore close vicinity to humans is probable. Many species are oligotrophic and have efficient nutrient scavenging systems. Toxin management has been hypothesized to enhance survival strategies in the environment ([@B27]), and industrial pollution by monoaromates might promote growth of these fungi near humans. In this scenario, take-up by susceptible individuals followed by successful infection, may explain their high frequency in CARD9 patients. The cytochrome P-450 gene family has been suggested as a possible factor explaining fungal neurotropism, but our clinical strain lacked PKS cluster 16 which is present in one of the environmental strains ([Figure 5](#F5){ref-type="fig"} and [Table 4](#T4){ref-type="table"}) and thus lacks benzoate 4-monooxygenase, an important gene in hydrocarbon catabolism.

Over the past decade, advances in Next Generation Sequencing (NGS) technologies and decreasing sequencing costs allowed an increase in the number of sequenced genomes, with better quality. Long-read sequencing technologies have contributed greatly to comparative genomics among species and can also be applied to study genomics within a species ([@B40]). The long-read sequencing method, [PACBIO]{.smallcaps}, has allowed the ability to obtain complete and accurate sequences. Genome data of our strains are listed in [Table 2](#T2){ref-type="table"}, showing a range of intraspecific variability of 863,280 bp and 87 genes. These genomes were sequenced by a combined Illumina and [PACBIO]{.smallcaps} strategy. We identify a relatively large core genome of 9,887 genes from our three genomes. The two environmental strains shared more genes (336) than a comparison with clinical strain ESC1. The clinical strain had 647 specific gene clusters. Comparing the genomes of *E. spinifera* sequenced to date, the older Illumina genomes were within the range of the above established species variance. Similarly, comparable numbers of genes were found, suggesting that published genomes are reliable, despite the fact that the number of scaffolds in the Illumina-only genomes was considerably higher.

In our study, the utility of long read sequencing is the possibility to investigate complex fungal genomes and characterize genomic variation. Despite surmised opportunism in black yeasts, our clinical strain of *E. spinifera*, derived from a CARD9-deficient patient, differed significantly from two environmental strains which originated from different continents. In the environmental/clinical comparison, rearrangements were observed in scaffolds I and III ([Figure 4](#F4){ref-type="fig"}), including two inversions, and ESC1 having an extra scaffold VIII ([Figure 4](#F4){ref-type="fig"}). The rearrangements in this genome area are significant ([Figure 4B](#F4){ref-type="fig"}). In contrast, clinical strain ESC1 was intermediate between the two environmental strains in numbers of SNPs and Indels. This suggests that the genomic rearrangements were a saltational event in an otherwise homogeneous population, as was noted in *Candida* after passage through a murine host ([@B23]). If, in contrast to *Candida, E. spinifera* is an opportunist residing in a non-human habitat, no transmission takes place after infection, and thus mutations are unlikely to be maintained in the population ([@B16]). The possibility cannot be excluded that the rearrangements were acquired during presence in the CARD9-deficient patient. Whether or not these may contribute to increased virulence of the species in an evolutionary step, as suggested by [@B8], or if they are lost as supposed by [@B16], requires study of a larger set of genomes and understanding of natural variability of *E. spinifera* in a wider array of habitats.

*E. spinifera* shows variable responses with hemolysis ([@B58]). Although these authors noted that this ability did not match with the division environmental/clinical, the possibility is not excluded that hemolytic strains have an enhanced invasive potency for vertebrate hosts. We registered up- or down-regulation of single-copy proteins in response to SDB vs. BHI, and noted that ESC1 showed significant differences with the two media in 16 single-copy genes, while the environmental strains remained almost indifferent; *in vitro*, ESC1 and ESE1 showed hemolysis, while ESE2 was negative. Most of the single-copy genes upregulated with BHI were transporters in KOG classification. Moreover, there were 48 unique genes differentially expressed exclusively to the clinical strain in two different media, including genes from various metabolic processes and transcriptional regulation. Up-regulated genes in clinical strain in GO enrichment were mainly involved in transmembrane transport, biosynthetic process, and metabolic process.

In this study, significant genomic rearrangements between strains of the same species were demonstrated. Two environmental strains from different continents were largely identical, whereas a clinical strain from a CARD9-deficient patient was different and deviated in the number of genes, even though all strains were phenotypically similar ([@B58]). In general, clinical and environmental strains of a single opportunistic fungus are taken to have comparable infectious abilities, because neither of them is equipped with specialized virulence factors. However, the observed quantitative genetic variability of strains of the single species *E. spinifera* possibly is associated with a differential chance to cause infection in susceptible patient populations; differences may be small but clinically relevant. We compared our NGS approach with older Illumina techniques, which showed some minor flaws e.g., in the number of scaffolds, but for quantitative description of the genome these data proved to be sufficient. The power of long reads obtained by [PACBIO]{.smallcaps} sequencing is to enable assembly of a complete genome sequence, which disclosed significant genomic rearrangements. Main improvement of [PACBIO]{.smallcaps} data are expected in qualitative studies of specific gene functions.
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